AC
Anurita Chopra
About Anurita Chopra
Data last updated:
Anurita Chopra is a Whole-Time Director at Glaxosmithkline Asia Private Limited (since 2016). The company operates in Healthcare. Glaxosmithkline Asia Private Limited reported revenue of ₹2,362 Cr (FY 2023).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Glaxosmithkline Asia Private Limited U99999PB1995PTC028476 | Whole-Time Director | 05 Sep 2016 | 1995 | ₹2,362 Cr (FY 2023) | Active |
Board colleagues of Anurita Chopra
| Name | DIN | Company | Designation |
|---|---|---|---|
| Kanika Shah Wadhwa | 08386613 | Glaxosmithkline Asia Private Limited | Whole-Time Director |
| Nitin Mathur | 09046346 | Glaxosmithkline Asia Private Limited | Whole-Time Director |
| Ramesh Chander Gupta | 02314913 | Glaxosmithkline Asia Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Anurita Chopra
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Anurita Chopra
Anurita Chopra currently holds 1 directorship: Glaxosmithkline Asia Private Limited (Whole-Time Director, since 05 Sep 2016, revenue ₹2,362 Cr (FY 2023)).
Anurita Chopra was first appointed on 05 Sep 2016 as Whole-Time Director at Glaxosmithkline Asia Private Limited.
The current boards of Anurita Chopra's companies include Kanika Shah Wadhwa (Glaxosmithkline Asia Private Limited), Nitin Mathur (Glaxosmithkline Asia Private Limited), Ramesh Chander Gupta (Glaxosmithkline Asia Private Limited).